COMPANY

Organix

Status: Acquired, now part of Symeres · How status works

Organix designs, synthesizes, purifies, and characterizes these bioconjugates and can incorporate small molecules. We work closely with you to ensure high-purity compounds with precise specifications, supporting advancements in pharmaceuticals, biotechnology, and material sciences. From company website Source · Oct 13, 2026

Keywords: small molecules pharmaceuticals compounds

Profile checked Oct 10, 2026

50NIH grants

NIH awards 50

Annual award amounts. Total $22.6M.

Jul 27, 2018 NIH award 5R44CA206723-03 FY2018: $743,502 awarded for that fiscal year; activity R44 (SBIR); PI MAHADEVAN, ANURADHA; recipient as written: ORGANIX, INC., WOBURN, MA. Targeting Breast Cancer Metastasis with Id1 source ↗
Jun 29, 2017 NIH award 4R44CA206723-02 FY2017: $809,827 awarded for that fiscal year; activity R44 (SBIR); PI MAHADEVAN, ANURADHA; recipient as written: ORGANIX, INC., WOBURN, MA. Targeting Breast Cancer Metastasis with Id1 source ↗
Aug 19, 2016 NIH award 1R44CA206723-01A1 FY2016: $178,146 awarded for that fiscal year; activity R44 (SBIR); PI MAHADEVAN, ANURADHA; recipient as written: ORGANIX, INC., WOBURN, MA. Targeting Breast Cancer Metastasis with Id1 source ↗
Aug 26, 2013 NIH award 1R43DA036289-01 FY2013: $279,256 awarded for that fiscal year; activity R43 (SBIR); PI MAHADEVAN, ANURADHA; recipient as written: ORGANIX, INC., WOBURN, MA. Cannabinoid Receptor Agonists for Treatment of Ch source ↗
May 1, 2013 NIH award 1R43CA171415-01A1 FY2013: $289,823 awarded for that fiscal year; activity R43 (SBIR); PI MAHADEVAN, ANURADHA; recipient as written: ORGANIX, INC., WOBURN, MA. Targeting breast cancer metastasis with inhibit source ↗
Aug 30, 2012 NIH award 1R43DA035006-01 FY2012: $250,001 awarded for that fiscal year; activity R43 (SBIR); PI MELTZER, PETER C; recipient as written: ORGANIX, INC., WOBURN, MA. The first reversible radioligand for the hVMAT2 [3H] source ↗
Aug 7, 2012 NIH award 5R43MH095315-02 FY2012: $331,270 awarded for that fiscal year; activity R43 (SBIR); PI SARD, HOWARD P; recipient as written: ORGANIX, INC., WOBURN, MA. Benzodiazepine Analogs as Novel Treatments for Cataton source ↗
Sep 16, 2011 NIH award 1R43MH095315-01 FY2011: $350,000 awarded for that fiscal year; activity R43 (SBIR); PI SARD, HOWARD P; recipient as written: ORGANIX, INC., WOBURN, MA. Benzodiazepine Analogs as Novel Treatments for Cataton source ↗
Jul 29, 2011 NIH award 5R03AI088542-02 FY2011: $103,455 awarded for that fiscal year; activity R03 (OTHER_NIH); PI HEGDE, VISHNUMURTHY R; recipient as written: ORGANIX, INC., WOBURN, MA. Novel 2'- and 3'- Branched Carbocyclic Nuc source ↗
Jun 27, 2011 NIH award 5R01DA005488-24 FY2011: $337,617 awarded for that fiscal year; activity R01 (OTHER_NIH); PI MAHADEVAN, ANURADHA; recipient as written: ORGANIX, INC., WOBURN, MA. Synthesis of delta9-Tetrahydrocannabinol Rel source ↗
Sep 21, 2010 NIH award 1R03AI088542-01 FY2010: $104,500 awarded for that fiscal year; activity R03 (OTHER_NIH); PI HEGDE, VISHNUMURTHY R; recipient as written: ORGANIX, INC., WOBURN, MA. Novel 2'- and 3'- Branched Carbocyclic Nuc source ↗
Jul 1, 2010 NIH award 5R01DA005488-23 FY2010: $348,059 awarded for that fiscal year; activity R01 (OTHER_NIH); PI MAHADEVAN, ANURADHA; recipient as written: ORGANIX, INC., WOBURN, MA. Synthesis of delta9-Tetrahydrocannabinol Rel source ↗
Feb 26, 2010 NIH award 5R03DA026593-02 FY2010: $238,343 awarded for that fiscal year; activity R03 (OTHER_NIH); PI MAHADEVAN, ANURADHA; recipient as written: ORGANIX, INC., WOBURN, MA. Development of CB2 Agonists for Treatment of source ↗
Jan 18, 2010 NIH award 3R44DK065322-04S1 FY2010: $96,281 awarded for that fiscal year; activity R44 (SBIR); PI SARD, HOWARD P; recipient as written: ORGANIX, INC., WOBURN, MA. Indole Analogs as Novel Appetite Suppressants source ↗
Jun 23, 2009 NIH award 5R01DA005488-22 FY2009: $351,575 awarded for that fiscal year; activity R01 (OTHER_NIH); PI MAHADEVAN, ANURADHA; recipient as written: ORGANIX, INC., WOBURN, MA. Synthesis of delta9-Tetrahydrocannabinol Rel source ↗
Feb 27, 2009 NIH award 1R03DA026593-01 FY2009: $264,375 awarded for that fiscal year; activity R03 (OTHER_NIH); PI MAHADEVAN, ANURADHA; recipient as written: ORGANIX, INC., WOBURN, MA. Development of CB2 Agonists for Treatment of source ↗
Sep 23, 2008 NIH award 3R43DK071377-02S1 FY2008: $23,736 awarded for that fiscal year; activity R43 (SBIR); PI MAHADEVAN, ANURADHA; recipient as written: ORGANIX, INC., WOBURN, MA. Novel THC/Anandamide Hybrids as Appetite Suppres source ↗
Aug 20, 2008 NIH award 5R44DK065322-04 FY2008: $394,714 awarded for that fiscal year; activity R44 (SBIR); PI SARD, HOWARD P; recipient as written: ORGANIX, INC., WOBURN, MA. Indole Analogs as Novel Appetite Suppressants source ↗
Jul 25, 2008 NIH award 1R43NS060210-01A1 FY2008: $130,505 awarded for that fiscal year; activity R43 (SBIR); PI MAHADEVAN, ANURADHA; recipient as written: ORGANIX, INC., WOBURN, MA. CB2 Agonists for Treatment of Neuropathic Pain. source ↗
Jul 9, 2008 NIH award 5R01DA005488-21 FY2008: $351,575 awarded for that fiscal year; activity R01 (OTHER_NIH); PI MAHADEVAN, ANURADHA; recipient as written: ORGANIX, INC., WOBURN, MA. Synthesis of delta9-Tetrahydrocannabinol Rel source ↗
Mar 27, 2008 NIH award 5R44MH063529-04 FY2008: $479,436 awarded for that fiscal year; activity R44 (SBIR); PI SARD, HOWARD P; recipient as written: ORGANIX, INC., WOBURN, MA. Indole Analogs as Novel Treatments for OCD source ↗
Mar 3, 2008 NIH award 5R01DA011542-10 FY2008: $379,817 awarded for that fiscal year; activity R01 (OTHER_NIH); PI MELTZER, PETER C; recipient as written: ORGANIX, INC., WOBURN, MA. Discovery of Novel Pharmacotherapies: Cocaine D source ↗
Feb 28, 2008 NIH award 5R01DA008904-13 FY2008: $190,490 awarded for that fiscal year; activity R01 (OTHER_NIH); PI RAZDAN, RAJ; recipient as written: ORGANIX, INC., WOBURN, MA. Anandamide -- Structure/Activity Relationships source ↗
Sep 1, 2007 NIH award 2R44DK065322-03 FY2007: $436,879 awarded for that fiscal year; activity R44 (SBIR); PI SARD, HOWARD P; recipient as written: ORGANIX, INC., WOBURN, MA. Indole Analogs as Novel Appetite Suppressants source ↗
Aug 3, 2007 NIH award 2R01DA005488-20 FY2007: $358,750 awarded for that fiscal year; activity R01 (OTHER_NIH); PI RAZDAN, RAJ; recipient as written: ORGANIX, INC., WOBURN, MA. Synthesis of delta9-Tetrahydrocannabinol Related Com source ↗
Apr 21, 2007 NIH award 5R44MH063529-03 FY2007: $469,609 awarded for that fiscal year; activity R44 (SBIR); PI SARD, HOWARD P; recipient as written: ORGANIX, INC., WOBURN, MA. Indole Analogs as Novel Treatments for OCD source ↗
Mar 26, 2007 NIH award 5R01DA008904-12 FY2007: $194,377 awarded for that fiscal year; activity R01 (OTHER_NIH); PI RAZDAN, RAJ; recipient as written: ORGANIX, INC., WOBURN, MA. Anandamide -- Structure/Activity Relationships source ↗
Mar 7, 2007 NIH award 5R01DA011542-09 FY2007: $387,569 awarded for that fiscal year; activity R01 (OTHER_NIH); PI MELTZER, PETER C; recipient as written: ORGANIX, INC., WOBURN, MA. Discovery of Novel Pharmacotherapies: Cocaine D source ↗
Jul 25, 2006 NIH award 5R43DK071377-02 FY2006: $244,419 awarded for that fiscal year; activity R43 (SBIR); PI MAHADEVAN, ANURADHA; recipient as written: ORGANIX, INC., WOBURN, MA. Novel THC/Anandamide Hybrids as Appetite Suppress source ↗
Jul 6, 2006 NIH award 5R01DA005488-19 FY2006: $350,320 awarded for that fiscal year; activity R01 (OTHER_NIH); PI RAZDAN, RAJ; recipient as written: ORGANIX, INC., WOBURN, MA. Delta9-Tetrahydrocannabinol Related Compounds source ↗